Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of October 8, 2026, GKOS trades at $173.85 with a market cap of $9.53B and a P/E ratio of -50.46. GKOS moved +0.97% today. Year to date, GKOS is +55.51%; over the trailing twelve months it is +104.76%. Its 52-week range spans $73.16 to $191.62. Analyst consensus is strong buy with an average price target of $197.33. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
13 analysts cover GKOS: 0 strong buy, 12 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $197.33.
| Metric | Value |
|---|---|
| Price | $173.85 |
| Market Cap | $9.53B |
| P/E Ratio | -50.46 |
| EPS | $-3.26 |
| Dividend Yield | 0.00% |
| 52-Week High | $191.62 |
| 52-Week Low | $73.16 |
| Volume | 1.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $612.84M |
| Net Income | $-188.05M |
| Gross Margin | 60.70% |
13 analysts cover GKOS: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $197.33.